Correlation Between KABE Group and SenzaGen
Can any of the company-specific risk be diversified away by investing in both KABE Group and SenzaGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KABE Group and SenzaGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KABE Group AB and SenzaGen AB, you can compare the effects of market volatilities on KABE Group and SenzaGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KABE Group with a short position of SenzaGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of KABE Group and SenzaGen.
Diversification Opportunities for KABE Group and SenzaGen
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between KABE and SenzaGen is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding KABE Group AB and SenzaGen AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SenzaGen AB and KABE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KABE Group AB are associated (or correlated) with SenzaGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SenzaGen AB has no effect on the direction of KABE Group i.e., KABE Group and SenzaGen go up and down completely randomly.
Pair Corralation between KABE Group and SenzaGen
Assuming the 90 days trading horizon KABE Group AB is expected to generate 0.47 times more return on investment than SenzaGen. However, KABE Group AB is 2.11 times less risky than SenzaGen. It trades about -0.02 of its potential returns per unit of risk. SenzaGen AB is currently generating about -0.15 per unit of risk. If you would invest 28,800 in KABE Group AB on December 2, 2024 and sell it today you would lose (600.00) from holding KABE Group AB or give up 2.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
KABE Group AB vs. SenzaGen AB
Performance |
Timeline |
KABE Group AB |
SenzaGen AB |
KABE Group and SenzaGen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with KABE Group and SenzaGen
The main advantage of trading using opposite KABE Group and SenzaGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KABE Group position performs unexpectedly, SenzaGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SenzaGen will offset losses from the drop in SenzaGen's long position.KABE Group vs. Byggmax Group AB | KABE Group vs. Svedbergs i Dalstorp | KABE Group vs. Inwido AB | KABE Group vs. New Wave Group |
SenzaGen vs. Simris Alg AB | SenzaGen vs. Immunovia publ AB | SenzaGen vs. Sedana Medical AB | SenzaGen vs. XSpray Pharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |